Stay updated on EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial
Sign up to get notified when there's something new on the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page.

Latest updates to the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe completed Phase 2 EN3835 study record is displayed, including its treatment design, eligibility criteria, locations, outcome measures, results, and study documents, instead of a 403 error screen.SummaryDifference57%

- Check20 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide banner announces an NIH website transition and says that some content will use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check34 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site's footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden screen instead of the study record details, replacing the usual content with a basic header and a Home link, signaling an access restriction or server error affecting the study page.SummaryDifference18%

Stay in the know with updates to EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page.